These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3931805)

  • 1. Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.
    Colin-Jones DG; Langman MJ; Lawson DH; Vessey MP
    Br Med J (Clin Res Ed); 1985 Oct; 291(6502):1084-8. PubMed ID: 3931805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.
    Colin-Jones DG; Langman MJ; Lawson DH; Vessey MP
    Br Med J (Clin Res Ed); 1983 May; 286(6379):1713-6. PubMed ID: 6405946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing surveillance of the safety of cimetidine: 10 year mortality report.
    Colin-Jones DG; Langman MJ; Lawson DH; Logan RF; Paterson KR; Vessey MP
    Gut; 1992 Sep; 33(9):1280-4. PubMed ID: 1358768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-marketing surveillance of the safety of cimetidine: twelve-month morbidity report.
    Colin Jones DG; Langman MJ; Lawson DH; Vessey MP
    Q J Med; 1985 Mar; 54(215):253-68. PubMed ID: 3991880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial].
    Amouretti M; Ansenay M; Bader JP; Baillet J; Bel A; Belaïche J; Benzenou A; Bertrand G; Bonfils S; Boucekkine T
    Gastroenterol Clin Biol; 1985 Feb; 9(2):147-52. PubMed ID: 3884426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim analysis of a comparative trial of ranitidine and cimetidine in the prevention of duodenal ulcer.
    Gough KR
    Am J Med; 1984 Nov; 77(5B):39-42. PubMed ID: 6095660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug surveillance. Monitoring the collateral effects of drugs in the post-marketing phase: cimetidine. I].
    Mariani L; Minora T
    Clin Ter; 1984 Apr; 109(1):3-17. PubMed ID: 6233077
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.
    Møller H; Nissen A; Mosbech J
    Gut; 1992 Sep; 33(9):1166-9. PubMed ID: 1358764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. The Belgian Peptic Ulcer Study Group.
    Gut; 1984 Sep; 25(9):999-1002. PubMed ID: 6088368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].
    Andersen M; Schou JS
    Ugeskr Laeger; 1991 May; 153(20):1410-3. PubMed ID: 1674181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
    Young MD; Lottes SR; Webb LA
    Clin Ther; 1988; 10(5):543-52. PubMed ID: 2856597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus.
    Colin-Jones DG; Langman MJ; Lawson DH; Logan RF; Paterson KR; Vessey MP
    Q J Med; 1991 Jan; 78(285):13-9. PubMed ID: 1670060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between ranitidine and cimetidine in the short-term treatment of duodenal ulcer.
    Capria A; Bresci G; Rindi G; Geloni M; Corsini G
    Int J Clin Pharmacol Res; 1985; 5(2):133-5. PubMed ID: 4018943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptic ulcer, cimetidine, and motor neurone disease--a record linkage study.
    Vessey MP; Goldacre MJ; Seagroatt V; Yeates D
    Gut; 1993 Dec; 34(12):1660-1. PubMed ID: 8282250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer.
    Walt RP; Hunt RH; Misiewicz JJ; Trotman I; Colley S; Dewar EP; Frost RA; Shepherd TH; Golding PL; Colin-Jones DG
    Scand J Gastroenterol; 1984 Nov; 19(8):1045-7. PubMed ID: 6099915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique postmarket outpatient surveillance program of cimetidine: report on phase II and final summary.
    Humphries TJ; Myerson RM; Gifford LM; Aeugle ME; Josie ME; Wood SL; Tannenbaum PJ
    Am J Gastroenterol; 1984 Aug; 79(8):593-6. PubMed ID: 6465106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer occurrence in a cohort of patients treated with cimetidine.
    Møller H; Lindvig K; Klefter R; Mosbech J; Møller Jensen O
    Gut; 1989 Nov; 30(11):1558-62. PubMed ID: 2599442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ranitidine and cimetidine in the treatment of chronic gastric ulcer. A double-blind trial.
    Kellow JE; Barr GD; Cowen AE; Ward M; Wood L; Piper DW
    Digestion; 1983; 27(2):105-10. PubMed ID: 6313458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.
    Colin-Jones DG; Langman MJ; Lawson DH; Vessey MP
    Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1311-3. PubMed ID: 6812688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.